SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
DRUG-DRUG INTERACTIONS: FROM PREDICTIONS TO MANAGEMENT
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
INTEGRATED DMPK ALGORITHM FOR THE PREDICTION OF ARV DDI MAGNITUDE (ABSTRACT
365)
Sandra Grañana-Castillo
University of Liverpool, Liverpool, Merseyside, United Kingdom
EXOGENOUS HORMONE PHARMACOKINETICS IN TRANSGENDER ADOLESCENTS RECEIVING ORAL TDF/FTC (ABSTRACT
366)
Jenna Lynn Yager
University of Colorado, Aurora, CO, USA
TFV-DP AND FTC-TP IN PBMC AMONG TRANSGENDER ADOLESCENTS RECEIVING DAILY TDF/FTC (ABSTRACT
367)
Jenna Lynn Yager
University of Colorado, Aurora, CO, USA
PHARMACOKINETICS OF 2 CONTRACEPTIVE IMPLANTS AMONG WOMEN ON RILPIVIRINE-BASED ART (ABSTRACT
368)
Shadia Nakalema
Infectious Diseases Institute, Kampala, Uganda
DRUG INTERACTIONS WITH ONCE-DAILY B/F/TAF IN COMBINATION WITH ONCE-WEEKLY RIFAPENTINE (ABSTRACT
369)
Priyanka Arora
Gilead Sciences, Inc, Foster City, CA, USA
EFFICACY AND PK OF DOLUTEGRAVIR 50 MG QD WITH FOOD VERSUS 50 MG BID WITH RIFAMPICIN (ABSTRACT
370)
Thornthun Ueaphongsukkit
HIV Netherlands-Australia-Thailand Research Collaboration, Thai Red Cross AIDS Research Centre, Bangkok, Thailand
INTRACELLULAR DISPOSITION OF DARUNAVIR/RITONAVIR AND DOLUTEGRAVIR WITH RIFAMPIN (ABSTRACT
371)
Amedeo De Nicolò
University of Turin, Torino, Italy
POTENTIAL DRUG-DRUG INTERACTIONS IN HOSPITALIZED COVID-19 PATIENTS (CATCO-DDI) (ABSTRACT
372)
Alice Tseng
Toronto General Hospital, Toronto, Canada
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
8 of
8
|
